Mohit Khera, MD, MBA, MPH

Mohit Khera, MD, MBA, MPH

Baylor College of Medicine

Houston, Texas

Mohit Khera, MD, MBA, MPH, is a Professor of Urology at Baylor College of Medicine in Houston, Texas, where he holds the F. Brantley Scott Chair in Urology. He additionally serves Baylor College as the Director of the Laboratory for Andrology Research at McNair Medical Institute and the Medical Director of the Executive Health Program. Dr. Khera specializes in male and female sexual dysfunction, men’s health, male infertility, sexual dysfunction, declining testosterone levels in aging men, and hormone replacement therapy. His research interests include studies on the efficacy of botulinum toxin type A in treating Peyronie’s disease, genetic and epigenetic studies of post-finasteride syndrome patients, and testosterone replacement therapy.

Dr. Khera earned his medical degree from the University of Texas Medical School at San Antonio. He then completed his residency in the Scott Department of Urology at Baylor College of Medicine in Houston, Texas, where he subsequently completed a one-year fellowship in Male Reproductive Medicine and Surgery under the guidance of Dr. Larry I. Lipshultz.  

Dr. Khera has authored or co-authored numerous book chapters, including those in the acclaimed Campbell-Walsh Urology textbook, Clinical Gynecology, and the fourth edition of Infertility in the Male. He also co-edited the third edition of the popular book Urology and the Primary Care Practitioner and published Recoupling: A Couple’s 4 Step Guide to Greater Intimacy and Better Sex. Dr. Khera has authored more than 90 articles in scientific journals and has lectured extensively worldwide on testosterone replacement therapy and sexual dysfunction. He is a member of the Sexual Medicine Society of North America, the American Urological Association, the American Society of Andrology, the American Medical Association, the Indian Doctors Association of Houston, the Harris County Medical Society, and the Texas Association of Genitourinary Surgeons. He serves on the Strategy and Development Committee for the International Society for Sexual Medicine and on the Board of Directors for the Society of Urologic Prosthetic Surgeons. 

Talks by Mohit Khera, MD, MBA, MPH

Testosterone Replacement and Focal Therapy

Mohit Khera, MD, MBA, MPH, reviews the literature surrounding the safety of testosterone replacement therapy (TRT) following prostate cancer treatment, including after brachytherapy, EBRT, and radical prostatectomy (RP). He also discusses the concept of bipolar androgen therapy (BAT) and the importance of TRT for erectile preservation post-RP.

Read More

2018 Update on Peyronie’s Disease: What’s Around the Bend

Mohit Khera, MD, MBA, MPH, a panel member for the 2015 American Urological Association (AUA) Peyronie’s disease (PD) guidelines, discusses the prevalence of PD and its correlation to low testosterone. Furthermore, he summarizes the AUA statements on intralesional injections, penile stretching devices, and surgical options. He explains future directions in this setting, as well, including data from animal models testing platelet-rich plasma (PRP) and stem cells.

Read More